EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mutational Profile in Romanian Patients with Hemophilia A

Andra Grigore iD, Mihaela Dragomir iD, Onda-Tabita Călugăru, Dumitru Jardan, Cerasela Jardan, Melen Brînză, Paul Bălănescu, Daniel Coriu

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Andra Grigore und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology (Clinic and Laboratory) Discipline-Fundeni Clinical Institute, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Roman…. Hauptthemen laut MEDLINE: Hemophilia A, Factor VIII, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Society of Hematology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemophilia A (HA) is an X-linked recessive bleeding disorder caused by mutations in the F8 gene, resulting in deficient or dysfunctional factor VIII (FVIII). This study aimed to characterize the mutational profile of HA in Romanian patients using next-generation sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA). A total of 107 patients were analyzed, revealing pathogenic or likely pathogenic variants in 96.3% of cases. The identified mutations included missense (30.5%), nonsense (9.1%), small deletions (6.4%), small insertions (2.1%), splice-site variants (4.3%), large deletions (1.6%), and large duplications (1.1%). Large intron inversion was previously found in 37.5% of the patients. Novel variants accounted for 21.5% of identified mutations, expanding the spectrum of F8 variants in this population. This study underscores the genetic heterogeneity of HA and provides insights into genotype–phenotype correlations, aiding in clinical management and prenatal diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AFactor VIIIHigh-Throughput Nucleotide SequencingHumansRomaniaMaleMutationFemaleAdultChildGenetic Association StudiesDNA Mutational Analysis

Stichwörter der Autor:innen

F8 genehemophilia Anext-generation sequencingnovel variant

Substanzen

Factor VIIIF8 protein, human

Autor:innen und Institutionen

  • Hematology (Clinic and Laboratory) Discipline-Fundeni Clinical Institute, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Department of Hematology and Bone Marrow Transplant, Fundeni Clinical Institute, 022328 Bucharest, Romania.
  • Molecular Biology Laboratory, Medlife, 010093 Bucharest, Romania.
  • Pediatrics Discipline-Fundeni Clinical Institute, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • Internal Medicine Discipline-Colentina Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.

ORCID-Profile: Andra Grigore, Mihaela Dragomir

Förderung

  • Romanian Society of Hematology

Zitieren

APA

Grigore, A., Dragomir, M., Călugăru, O. T., Jardan, D., Jardan, C., Brînză, M., Bălănescu, P., & Coriu, D. (2024). Mutational Profile in Romanian Patients with Hemophilia A. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158366

Vancouver

Grigore A, Dragomir M, Călugăru OT, Jardan D, Jardan C, Brînză M, et al. Mutational Profile in Romanian Patients with Hemophilia A. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158366

BibTeX
@article{Grigore2024,
  author = {Grigore, Andra and Dragomir, Mihaela and Călugăru, Onda-Tabita and Jardan, Dumitru and Jardan, Cerasela and Brînză, Melen and Bălănescu, Paul and Coriu, Daniel},
  title = {Mutational Profile in Romanian Patients with Hemophilia A},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158366}
}
Kostenlos starten →